financetom
Business
financetom
/
Business
/
GFG Resources Starts 3,000 Metre Drill Program at Aljo While Making Regional Pipeline Progress Across Goldarm and Pen
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GFG Resources Starts 3,000 Metre Drill Program at Aljo While Making Regional Pipeline Progress Across Goldarm and Pen
Sep 8, 2025 9:54 AM

12:30 PM EDT, 09/08/2025 (MT Newswires) -- GFG Resources Inc ( GFGSF ) shares moved higher on Monday after the company said it launched a 3,000-meter diamond drill program at the Aljo gold project in northern Ontario.

The project, located on the east side of the company's Goldarm property in the Timmins Gold Districto, is designed to confirm grade continuity in the main zone, extend multiple hanging wall zones, and expand the footwall corridor, including the new FW3 (footwall) discovery.

The company also highlighted its regional work progress along a 10-kilometer stretch of the Pipestone Deformation corridor at Goldarm and stated it will extend through the second half of 2025 and the first quarter of 2026. Lastly, GFG is advancing priority targets at the Pen Gold Project and putting greater emphasis on the Chabot and Muskego locations.

"Aljo continues to check the boxes we look for in Timmins - grade, continuity and room to grow. This program aims to convert and extend high-grade shoots in the Main and HW Zones while testing the FW system, where FW3 opens a compelling new front. Coupled with larger step-outs and a broader push along the Pipestone Deformation corridor, we see multiple catalysts lining up over the remainder of 2025 and well into 2026," said chief executive Brian Skanderbeg.

Shares of GFG Resources ( GFGSF ) were last seen up $0.01 to $0.15 on the TSX Venture Exchange.

Price: 0.15, Change: +0.01, Percent Change: +7.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bausch + Lomb Targets Above-Market Growth, Double-Digit EPS Gains Through 2028
Bausch + Lomb Targets Above-Market Growth, Double-Digit EPS Gains Through 2028
Nov 13, 2025
08:54 AM EST, 11/13/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) , up 2.4% in U.S. pre-market trading, said Thursday it will present its transformation and growth strategy at an investor day event at the New York Stock Exchange today. The event will focus on the company's rebuilt product pipeline. Total projected peak sales of pipeline products, with...
TKO Partners With Polymarket to Integrate Prediction Market Into Fight Events
TKO Partners With Polymarket to Integrate Prediction Market Into Fight Events
Nov 13, 2025
08:52 AM EST, 11/13/2025 (MT Newswires) -- TKO Group Holding (TKO) said Thursday that it has formed a multi-year partnership with Polymarket, in which Polymarket will be named the official and exclusive prediction market partner of mixed martial arts' UFC as well as Zuffa Boxing events. TKO said UFC and Zuffa Boxing will integrate Polymarket's prediction market technology into the...
South African media get funding package from Google after antitrust probe
South African media get funding package from Google after antitrust probe
Nov 13, 2025
By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -South Africa's competition regulator announced on Thursday a series of concessions from global tech platforms, including a 688 million rand ($40 million) media support package agreed with Google and YouTube, following an investigation into the sector. The package, announced in the Competition Commission's final report of its Media and Digital Platforms Market...
Xenetic Biosciences Q3 revenue up 67.2% on royalty gains
Xenetic Biosciences Q3 revenue up 67.2% on royalty gains
Nov 13, 2025
Overview * Xenetic Q3 revenue rises 67.2% yr/yr, driven by increased royalty revenue * Net loss for Q3 2025 was $0.5 mln, with increased R&D expenses * Company secured $3.9 mln from October 2025 offering to extend cash runway Outlook * Xenetic advances DNase technology towards Phase 1 clinical trials for solid tumors * Company plans to invest in pre-clinical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved